Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding

This week's local life sciences industry news includes details on a Philadelphia biotech company achieving an FDA first, a gift that will expand treatment options at a local ALS center, and more.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.